Niemann-pick C1-like 1 overexpression facilitates ezetimibe-sensitive cholesterol and β-sitosterol uptake in CaCo-2 cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 2, 2007, Pages 559-564

  Yamanashi, Yoshihide ^a   Takada, Tappei ^a   Suzuki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; EZETIMIBE; MEMBRANE PROTEIN; PHOSPHATIDYLCHOLINE; PROTEIN NPC1L1; SITOSTEROL; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

APICAL MEMBRANE; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG UPTAKE; GENE CONSTRUCT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICELLE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; CACO-2 CELLS; CHOLESTEROL; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICELLES; PHOSPHATIDYLCHOLINES; SITOSTEROLS; TAUROCHOLIC ACID;

EID: 33846421597     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.114181     Document Type: Article

References (19)

1. Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, et al. (2004) Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science (Wash DC) 303:1201-1204.
2. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, and Hobbs HH (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science (Wash DC) 290:1771-1775.
3. Davies JP, Scott C, Oishi K, Liapis A, and Ioannou YA (2005) Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J Biol Chem 280:12710-12720.
4. Davis HR Jr, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, Yao X, Iyer SP, Lam MH, Lund EG, et al. (2004) Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 279:33586-33592.
5. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR Jr, Dean DC, Detmers PA, et al. (2005) The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1). Proc Natl Acad Sci USA 102:8132-8137.
6. Garmy N, Taieb N, Yahi N, and Fantini J (2005) Interaction of cholesterol with sphingosine: physicochemical characterization and impact on intestinal absorption. J Lipid Res 46:36-45.
7. Horter D and Dressman JB (2001) Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 46:75-87.
8. Hui DY and Howles PN (2005) Molecular mechanisms of cholesterol absorption and transport in the intestine. Semin Cell Dev Biol 16:183-192.
9. Iyer SP, Yao X, Crona JH, Hoos LM, Tetzloff G, Davis HR Jr, Graziano MP, and Altmann SW (2005) Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 like 1 (NPC1L1) protein. Biochim Biophys Acta 1722:282-292.
10. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
11. Patel J, Sheehan V, and Gurk-Turner C (2003) Ezetimibe (Zetia): a new type of lipid-lowering agent. Proc (Bayl Univ Med Cent) 16:354-358.
12. Proulx P, Aubry H, Brglez I, and Williamson DG (1984) The effect of phosphoglycerides on the incorporation of cholesterol into isolated brush-border membranes from rabbit small intestine. Biochim Biophys Acta 775:341-346.
13. Salen G, von Bergmann K, Lutjohann D, Kwiterovich P, Kane J, Patel SB, Musliner T, Stein P, and Musser B (2004) Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 109:966-971.
14. Sane AT, Sinnett D, Delvin E, Bendayan M, Marcil V, Menard D, Beaulieu JF, and Levy E (2006) Localization and role of NPC1L1 in cholesterol absorption in human intestine. J Lipid Res 47:2112-2120.
15. van Heek M, Compton DS, and Davis HR (2001) The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. Eur J Pharmacol 415:79-84.
16. von Bergmann K, Sudhop T, and Lutjohann D (2005) Cholesterol and plant sterol absorption: recent insights. Am J Cardiol 96:10D-14D.
17. Wang J, Williams CM, and Hegele RA (2005) Compound heterozygosity for two non-synonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe. Clin Genet 67:175-177.
18. Woollett LA, Wang Y, Buckley DD, Yao L, Chin S, Granholm N, Jones PJ, Setchell KD, Tso P, and Heubi JE (2006) Micellar solubilisation of cholesterol is essential for absorption in humans. Gut 55:197-204.
19. Yu L, Bharadwaj S, Brown JM, Ma Y, Du W, Davis MA, Michaely P, Liu P, Willingham MC, and Rudel LL (2006) Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem 281:6616-6624.